The use of adenoviral vectors in gene therapy and vaccine approaches

The use of adenoviral vectors in gene therapy and vaccine approaches

Abstract Adenovirus was first identified in the 1950s and since then this pathogenic group of viruses has been explored and transformed into a genetic transfer vehicle. Modification or deletion of few genes are necessary to transform it into a conditionally or non-replicative vector, creating a vers...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura
Μορφή:	Άρθρο
Γλώσσα:	English
Έκδοση:	Sociedade Brasileira de Genética 2022-10-01
Σειρά:	Genetics and Molecular Biology
Θέματα:	Adenovirus gene therapy monogenic diseases cancer vaccines
Διαθέσιμο Online:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000400108&tlng=en

Παρόμοια τεκμήρια

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
ανά: Jingao Guo, κ.ά.
Έκδοση: (2018-07-01)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
ανά: Lynda Coughlan
Έκδοση: (2020-05-01)

Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
ανά: Luca Scarsella, κ.ά.
Έκδοση: (2024-02-01)

Improving adenoviral vectors and strategies for prostate cancer gene therapy
ανά: Rodrigo Esaki Tamura, κ.ά.
Έκδοση: (2018-08-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
ανά: L. V. Cherenova, κ.ά.
Έκδοση: (2017-08-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
ανά: L. V. Cherenova, κ.ά.
Έκδοση: (2017-05-01)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
ανά: Meirong Wang, κ.ά.
Έκδοση: (2021-03-01)

Progress in Adenoviral Capsid-Display Vaccines
ανά: Marija Vujadinovic, κ.ά.
Έκδοση: (2018-07-01)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
ανά: Alessandra Vitelli, κ.ά.
Έκδοση: (2017-12-01)

Adenoviral vectors for gene therapy /
ανά: Curiel, David T., κ.ά.
Έκδοση: (2002)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
ανά: César López-Camacho, κ.ά.
Έκδοση: (2020-06-01)

Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
ανά: Mirian Galliote Morale, κ.ά.
Έκδοση: (2022-02-01)

Response Type and Host Species may be Sufficient to Predict Dose-Response Curve Shape for Adenoviral Vector Vaccines
ανά: John Benest, κ.ά.
Έκδοση: (2020-03-01)

A New Look at Vaccine Strategies Against PPRV Focused on Adenoviral Candidates
ανά: José M. Rojas, κ.ά.
Έκδοση: (2021-09-01)

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
ανά: Vidthiya Jeyanathan, κ.ά.
Έκδοση: (2022-06-01)

Construction and application of adenoviral vectors
ανά: Hongbo Zhang, κ.ά.
Έκδοση: (2023-12-01)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
ανά: Qiwei Zhang, κ.ά.
Έκδοση: (2022-03-01)

The Role of Chromatin in Adenoviral Vector Function
ανά: Carmen M. Wong, κ.ά.
Έκδοση: (2013-06-01)

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
ανά: Vidthiya Jeyanathan, κ.ά.
Έκδοση: (2023-02-01)

Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus
ανά: Erika M. Petro-Turnquist, κ.ά.
Έκδοση: (2022-06-01)

Intranasally Delivered Adenoviral Vector Protects Chickens against Newcastle Disease Virus: Vaccine Manufacturing and Stability Assessments for Liquid and Lyophilized Formulations
ανά: Omar Farnós, κ.ά.
Έκδοση: (2023-12-01)

Immunologic Dose-Response to Adenovirus-Vectored Vaccines in Animals and Humans: A Systematic Review of Dose-Response Studies of Replication Incompetent Adenoviral Vaccine Vectors when Given via an Intramuscular or Subcutaneous Route
ανά: Sara Afrough, κ.ά.
Έκδοση: (2020-03-01)

Single-cycle adenovirus vectors in the current vaccine landscape
ανά: Michael Barry
Έκδοση: (2018-02-01)

Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
ανά: Wen-Chien Wang, κ.ά.
Έκδοση: (2022-12-01)

Adenoviral Keratoconjunctivitis
ανά: Alexander Bialasiewicz
Έκδοση: (2007-04-01)

Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents
ανά: Joshua Del Papa, κ.ά.
Έκδοση: (2017-01-01)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
ανά: Dulce Mata-Espinosa, κ.ά.
Έκδοση: (2023-10-01)

TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line
ανά: Mirian Galliote Morale, κ.ά.
Έκδοση: (2022-04-01)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
ανά: Catherine Collignon, κ.ά.
Έκδοση: (2020-11-01)

Developments in Viral Vector-Based Vaccines
ανά: Takehiro Ura, κ.ά.
Έκδοση: (2014-07-01)

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
ανά: Cal Koger-Pease, κ.ά.
Έκδοση: (2023-02-01)

Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes
ανά: Groitl Peter, κ.ά.
Έκδοση: (2011-09-01)

Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
ανά: Andrew H. Baker, κ.ά.
Έκδοση: (2010-10-01)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
ανά: Adam Berg, κ.ά.
Έκδοση: (2021-10-01)

Current development in adenoviral vectors for cancer immunotherapy
ανά: Greyson Willis Grossman Biegert, κ.ά.
Έκδοση: (2021-12-01)

Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies
ανά: Chinonyerem O. Iheanacho, κ.ά.
Έκδοση: (2022-03-01)

The prevalence of adenoviral conjunctivitis at the Clinical Hospital of the State University of Campinas, Brazil
ανά: Roberto Damian Pacheco Pinto, κ.ά.
Έκδοση: (2015-11-01)

Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
ανά: Heikki Saari, κ.ά.
Έκδοση: (2020-01-01)

Application of adenovirus vector in cancer gene therapyand vaccination
ανά: Xie Qian, κ.ά.
Έκδοση: (2021-03-01)

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV
ανά: Senthil K. Chinnakannan, κ.ά.
Έκδοση: (2020-04-01)